Impacts of Mitochondrial-targeted Antioxidant on Peripheral Artery Disease Patients
NCT03506633
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Arterial Disease
Peripheral Artery Disease
Interventions
DIETARY_SUPPLEMENT:
MitoQ
Sponsor
University of Nebraska